Novo’s Wegovy Pill Crushes Lilly’s Foundayo in Early Weight-Loss Battle
Novo Nordisk’s Wegovy pill is dominating early sales with 8x more prescriptions than Eli Lilly’s Foundayo.
/ 60 items
#XY News-Driven Stocks↓
CONMED Weighs Strategic Sale as Takeover Interest Emerges
The Florida-based surgical device maker faces margin pressures but sees strong interest from acquirers.
Qiagen Draws Early Takeover Interest from EQT, Advent, and KKR
No formal bids yet as the ~$9B molecular diagnostics leader faces sector consolidation.
Alignment Healthcare Hit with Whistleblower Lawsuit Over Alleged Accounting Manipulation
A whistleblower has accused Medicare Advantage insurer Alignment Healthcare of misclassifying expenses to inflate earnings.
Short Seller Culper Attacks Tarsus Pharmaceuticals Over XDEMVY Market Size
Culper Research argues Tarsus is significantly overvalued, disputing the addressable market for its Demodex blepharitis drug XDEMVY.
QuidelOrtho Eyes $1.5B Sale of COVID-Era Rapid Testing Business
The unit, once a pandemic star, attracts strong private equity interest.